Comparison of long-term results of individualized and conventional exenteration for treatment of ocular surface tumors: a prospective randomized controlled trial

Long-term results of individualized subtotal exenteration for treatment of advanced ocular surface tumors

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000037225

Enrollment

Unknown

Registered

2020-08-27

Start date

2020-08-26

Completion date

Unknown

Last updated

2020-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ocular Surface Tumors

Interventions

Individualized Subtotal Exenteration:Treated with Individualized Subtotal Exenteration

Conventional Exenteration:Treated with Conventional Exenteration

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 18 to 88-year old subjects with advanced ocular surface tumors; the largest basal diameter<25mm.

Exclusion criteria

Exclusion criteria: Regional invasion of orbital septum, lower part of nasolacrimal duct, nasal cavity, or paranasal sinuses; Distant metastasis.

Design outcomes

Primary

Measure	Time frame
Overall Survival Rate;Time to Wound Healing;Hollow Appearance;	—

Secondary

Measure	Time frame
Disease-free Survival Rate;Distant Metastasis-free Survival Rate;Local Recurrence Rate;Regional Lymph Node Metastasis Rate;Distant Metastasis Rate;	—

Countries

China

Contacts

Public ContactJiang Qian

Fudan Eye & ENT Hospital

qianjiang@fudan.edu.cn+86 21 64377134

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026